Needham, KeyBanc Raise Cryoport Price Targets After Q3 Results
Needham maintained its Buy rating and raised its target to $28 from $19. KeyBanc maintained its Overweight rating and lifted its target to $20 from $17.
In response to Cryoport's third-quarter 2026 financial performance and updated guidance, investment analysts adjusted their outlooks on the company. Needham maintained its 'Buy' rating and raised its price target to $28 from $19. Similarly, Keybanc maintained its 'Overweight' rating and increased its price target to $20 from $17. These adjustments reflect analyst sentiment following the company's revenue beat and improved full-year outlook.